DRUG: Zanubrutinib
DRUG: Tafasitamab
BIOLOGICAL: Zilovertamab vedotin
DRUG: Nemtabrutinib
DRUG: Zanubrutinib
DRUG: Obinutuzumab
DRUG: Venetoclax
DRUG: LP-168
DRUG: LP-168
DRUG: Odronextamab
DRUG: ABBV-291
BIOLOGICAL: Autologous BAFFR-targeting CAR T Cells
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: NKX019
DRUG: AVM0703
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Lenalidomide
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclophosphamide
BIOLOGICAL: Cytokine-treated Veto Cells
DRUG: Fludarabine
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation
DRUG: voruciclib monotherapy
DRUG: voruciclib and venetoclax
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
DRUG: Venetoclax
DRUG: Lenalidomide
DRUG: Rituximab
DRUG: CD47 Antagonist ALX148
DRUG: Lenalidomide
BIOLOGICAL: Rituximab
DRUG: AC676
DRUG: NX-2127
DRUG: Selinexor
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
DRUG: ATA3219
DRUG: Acalabrutinib
DRUG: Rituximab
OTHER: Brexucabtagene Autoleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
RADIATION: Viewray MRIdian® Linac
DRUG: Zanubrutinib
DRUG: Acalabrutinib
BIOLOGICAL: Obinutuzumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: CD22CART Infusion
DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
BIOLOGICAL: CTX112
DRUG: IKS03
DRUG: Tazemetostat Pill
DRUG: Venetoclax Oral Tablet [Venclexta]
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
BIOLOGICAL: Glofitamab
DRUG: Lenalidomide
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography
DRUG: Venetoclax
DRUG: AZD5492
DRUG: Acalabrutinib
DRUG: Venetoclax
DRUG: Obinutuzumab
DRUG: Polatuzumab vedotin
DRUG: Docirbrutinib
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Myeloablative Conditioning
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Rituximab
DRUG: Bendamustine
DRUG: Lenalidomide
DRUG: Tocilizumab
DRUG: SGR-1505
DRUG: CD79b-19 CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: L-Bcl-2 antisense oligonucleotide
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: Pirtobrutinib
DRUG: Venetoclax
RADIATION: Adaptive Bridging Radiation Therapy (ABRT)
DRUG: Acalabrutinib
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
DRUG: Pirtobrutinib
DRUG: Brexucabtagene Autoleucel
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
DRUG: Venetoclax
DRUG: Low Dose Radiation Therapy
DRUG: ABBV-101
BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T
DRUG: BGB-16673
BIOLOGICAL: Loncastuximab Tesirine
DRUG: Acalabrutinib
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Doxorubicin Hydrochloride
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Rituximab and Hyaluronidase Human
BIOLOGICAL: BAFFR-CAR T cells
DRUG: NX-5948
DRUG: SC262
DRUG: Zanubrutinib
BIOLOGICAL: Rituximab
OTHER: Patient Observation
PROCEDURE: Bone Marrow Biopsy
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Esophagogastroduodenoscopy
PROCEDURE: Colonoscopy
PROCEDURE: Biospecimen Collection
OTHER: Questionnaire Administration
DRUG: CAR.k.28
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
DRUG: Rituximab
DRUG: Pirtobrutinib
DRUG: SYNCAR-001
DRUG: STK-009
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: ONM-501
DRUG: Cemiplimab
DRUG: Acalabrutinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
BIOLOGICAL: Glofitamab
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Obinutuzumab
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
BIOLOGICAL: EGFRt/19-28z/IL-12 CAR T-lymphocytes
DRUG: Fludarabine Phosphate
PROCEDURE: Leukapheresis
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Tocilizumab
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
DRUG: Epcoritamab
DRUG: Lenalidomide
DRUG: Ibrutinib
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride [HCl]
DRUG: Prednisone
DRUG: Polatuzumab Vedotin
DRUG: Venetoclax
DRUG: CC-99282
DRUG: Pirtobrutinib
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells
BIOLOGICAL: SynKIR-310
Get the latest thought leadership on your Mantle Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.